274 related articles for article (PubMed ID: 22102868)
21. Combined analysis of murine and human microarrays and ChIP analysis reveals genes associated with the ability of MYC to maintain tumorigenesis.
Wu CH; Sahoo D; Arvanitis C; Bradon N; Dill DL; Felsher DW
PLoS Genet; 2008 Jun; 4(6):e1000090. PubMed ID: 18535662
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
Cutrona G; Carpaneto EM; Ponzanelli A; Ulivi M; Millo E; Scarfì S; Roncella S; Benatti U; Boffa LC; Ferrarini M
Cancer Res; 2003 Oct; 63(19):6144-8. PubMed ID: 14559793
[TBL] [Abstract][Full Text] [Related]
23. Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas.
Ciribilli Y; Singh P; Spanel R; Inga A; Borlak J
Oncotarget; 2015 Oct; 6(31):31569-92. PubMed ID: 26427040
[TBL] [Abstract][Full Text] [Related]
24. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines.
Cariati R; Zancai P; Quaia M; Cutrona G; Giannini F; Rizzo S; Boiocchi M; Dolcetti R
Int J Cancer; 2000 May; 86(3):375-84. PubMed ID: 10760826
[TBL] [Abstract][Full Text] [Related]
25. Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures.
Johnston HE; Carter MJ; Cox KL; Dunscombe M; Manousopoulou A; Townsend PA; Garbis SD; Cragg MS
Mol Cell Proteomics; 2017 Mar; 16(3):386-406. PubMed ID: 28062796
[TBL] [Abstract][Full Text] [Related]
26. Piperlongumine inhibits proliferation and survival of Burkitt lymphoma in vitro.
Han SS; Son DJ; Yun H; Kamberos NL; Janz S
Leuk Res; 2013 Feb; 37(2):146-54. PubMed ID: 23237561
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus reactivation induces MYC-IGH spatial proximity and t(8;14) in B cells.
Sall FB; Shmakova A; Karpukhina A; Tsfasman T; Lomov N; Canoy RJ; Boutboul D; Oksenhendler E; Toure AO; Lipinski M; Wiels J; Germini D; Vassetzky Y
J Med Virol; 2023 Mar; 95(3):e28633. PubMed ID: 36866703
[TBL] [Abstract][Full Text] [Related]
28. Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma.
Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Niino D; Ohshima K
Pathol Int; 2015 Sep; 65(9):486-9. PubMed ID: 26182827
[TBL] [Abstract][Full Text] [Related]
29. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression.
Habel ME; Lemieux R; Jung D
J Cell Physiol; 2005 Apr; 203(1):277-85. PubMed ID: 15468060
[TBL] [Abstract][Full Text] [Related]
30. Myc suppression of Nfkb2 accelerates lymphomagenesis.
Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
[TBL] [Abstract][Full Text] [Related]
31. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
[TBL] [Abstract][Full Text] [Related]
32. c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma.
Ciribilli Y; Singh P; Inga A; Borlak J
Oncotarget; 2016 Oct; 7(40):65514-65539. PubMed ID: 27602772
[TBL] [Abstract][Full Text] [Related]
33. MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells.
Mazzoccoli L; Robaina MC; Apa AG; Bonamino M; Pinto LW; Queiroga E; Bacchi CE; Klumb CE
J Cancer Res Clin Oncol; 2018 Mar; 144(3):483-497. PubMed ID: 29318382
[TBL] [Abstract][Full Text] [Related]
34. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma.
López C; Kleinheinz K; Aukema SM; Rohde M; Bernhart SH; Hübschmann D; Wagener R; Toprak UH; Raimondi F; Kreuz M; Waszak SM; Huang Z; Sieverling L; Paramasivam N; Seufert J; Sungalee S; Russell RB; Bausinger J; Kretzmer H; Ammerpohl O; Bergmann AK; Binder H; Borkhardt A; Brors B; Claviez A; Doose G; Feuerbach L; Haake A; Hansmann ML; Hoell J; Hummel M; Korbel JO; Lawerenz C; Lenze D; Radlwimmer B; Richter J; Rosenstiel P; Rosenwald A; Schilhabel MB; Stein H; Stilgenbauer S; Stadler PF; Szczepanowski M; Weniger MA; Zapatka M; Eils R; Lichter P; Loeffler M; Möller P; Trümper L; Klapper W; ; Hoffmann S; Küppers R; Burkhardt B; Schlesner M; Siebert R
Nat Commun; 2019 Mar; 10(1):1459. PubMed ID: 30926794
[TBL] [Abstract][Full Text] [Related]
35. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
Ben-Yosef T; Yanuka O; Benvenisty N
Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
[TBL] [Abstract][Full Text] [Related]
36. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
[TBL] [Abstract][Full Text] [Related]
37. Transcriptome regulation and chromatin occupancy by E2F3 and MYC in mice.
Tang X; Liu H; Srivastava A; Pécot T; Chen Z; Wang Q; Huang K; Sáenz-Robles MT; Cantalupo P; Pipas J; Leone G
Sci Data; 2016 Feb; 3():160008. PubMed ID: 26881867
[TBL] [Abstract][Full Text] [Related]
38. Genome-Wide Analysis of c-MYC-Regulated mRNAs and miRNAs and c-MYC DNA-Binding by Next-Generation Sequencing.
Jackstadt R; Kaller M; Menssen A; Hermeking H
Methods Mol Biol; 2021; 2318():119-160. PubMed ID: 34019289
[TBL] [Abstract][Full Text] [Related]
39. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.
Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R
Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752
[TBL] [Abstract][Full Text] [Related]
40. A recurrent clonally distinct Burkitt lymphoma case highlights genetic key events contributing to oncogenesis.
Penther D; Viailly PJ; Latour S; Etancelin P; Bohers E; Vellemans H; Camus V; Menard AL; Coutant S; Lanic H; Lemasle E; Drieux F; Veresezan L; Ruminy P; Raimbault A; Soulier J; Frebourg T; Tilly H; Jardin F
Genes Chromosomes Cancer; 2019 Aug; 58(8):595-601. PubMed ID: 30779244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
